SKYRIZI
Showing 1 - 25 of 41
Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)
Not yet recruiting
- Genital Psoriasis
- Scalp Psoriasis
- Risankizumab
- Placebo for Risankizumab
- (no location specified)
Jul 24, 2023
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)
Not yet recruiting
- Juvenile Psoriatic Arthritis
- (no location specified)
Oct 20, 2023
Healthy Volunteers Trial in Shanghai (Risankizumab)
Completed
- Healthy Volunteers
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital /ID# 212830
Mar 3, 2022
Psoriasis Trial in Portland (risankizumab)
Active, not recruiting
- Psoriasis
-
Portland, OregonOregon Medical Research Center
Aug 15, 2022
Psoriasis Trial in New York (Risankizumab-Rzaa, Punch biopsies of the skin at baseline visit, Punch biopsies of the skin at week
Recruiting
- Psoriasis
- Risankizumab-Rzaa
- +2 more
-
New York, New YorkThe Rockefeller Univesity
Jun 9, 2022
Arthritis, Psoriatic, Healthy Trial in Graz (Guselkumab, Risankizumab)
Terminated
- Arthritis, Psoriatic
- Healthy
-
Graz, AustriaMedical University Graz
Jul 22, 2022
Healthy Volunteers Trial in Cypress (Risankizumab, Placebo)
Completed
- Healthy Volunteers
- Risankizumab
- Placebo
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc /ID# 164197
Mar 23, 2022
Psoriasis Trial (SKYRIZI)
Unknown status
- Psoriasis
- SKYRIZI
- (no location specified)
Jan 26, 2021
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Assess Participant-Reported Real-World Experience of
Recruiting
- Crohn's Disease
-
London, London, City Of, United KingdomGuys and St Thomas NHS Foundation Trust /ID# 258986
Nov 7, 2023
Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)
Active, not recruiting
- Palmoplantar Pustulosis (PPP)
- Risankizumab
- Placebo
-
Ichinomiya-shi, Aichi, Japan
- +38 more
Mar 1, 2022